Virvio Company
Developer of a broadly-protective influenza therapeutic.
Estimated Revenue:
Less than $1M
Industry:
Early Drug Development
Investors Number:
1.0
Last Funding Date:
2016-02-15
Technology:
Early Drug Development
Founded Date:
2015-12-01
Headquarters:
Seattle, Washington, United States
Total Funding:
209000.0
Last Funding Type:
Grant
Employee Number:
1-10